Leila Darki

Dr Leila Darki completed a residency in neurology, as well as a fellowship in clinical neurophysiology and electromyography at Keck Medicine of USC ( University of Southern California), where she subsequently joined as a faculty member in the Neuromuscular division.

Her clinical interests include amyotrophic lateral sclerosis, myasthenia gravis, acquired and inherited muscle disease and neuropathies. Dr Darki ‘s approach to patients consists of comprehensive evaluation including neurophysiological testing and other diagnostic procedures such as neuromuscular ultrasound, muscle and skin biopsies.

Dr. Darki is a board certified, neurologist and advocates an integrated approach to management of neuromuscular disorders. Dr. Darki is a collaborating physician and active member at the keck Medicine of USC ALS clinic.

• A novel case of compound heterozygous GFPT1 congenital myasthenic syndrome with a coexisting heterozygous DYSF mutation: clinical and pathological insights. Neurol Sci. 2026 Jan 17; 47(1):170.. View in PubMed
• Paraproteinemic Neuropathies. Continuum (Minneap Minn). 2023 10 01; 29(5):1492-1513.. View in PubMed
• Reducing body myopathy associated with the LIM2 p.(His123Arg) FHL1 variant. Clin Neurol Neurosurg. 2021 08; 207:106795.. View in PubMed
• Polyneuropathy Reveals Origins of Decade-long Gastrointestinal Symptoms in a Patient With Undiagnosed Mitochondrial Neurogastrointestinal Encephalopathy Caused by a Novel Mutation. J Clin Neuromuscul Dis. 2020 Dec; 22(2):97-102.. View in PubMed
• Development of In-Office Laryngeal Nerve Conduction Studies: Computed Tomography and Cadaveric Study. Laryngoscope. 2021 07; 131(7):1566-1569.. View in PubMed
• In-hospital mortality and coronary procedure use for individuals with dementia with acute myocardial infarction in the United States. J Am Geriatr Soc. 2013 Nov; 61(11):1932-6.. View in PubMed

• Beydoun, Said